Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Fresenius Kabi Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (279)
Cancellation by sponsor (145)
Prescription medicine registration (13)
Australian Public Assessment Report (AusPAR) (6)
Prescription medicine decision summary (2)

Date

2026 (14)
2025 (21)
2024 (49)
2023 (45)
2022 (28)
2021 (12)
2020 (28)
2019 (56)
2018 (15)
2017 (14)
2016 (16)
2015 (18)
2014 (7)
2013 (25)
2012 (18)
2011 (5)
2010 (5)
2009 (1)
2008 (13)
2007 (11)
2006 (26)
2002 (2)
2001 (2)
1994 (5)
1992 (3)
1991 (6)

Search

Sponsor content

445 result(s) found, displaying 341 to 350

FRESOFOL 1% MCT/LCT propofol 200mg/20mL emulsion for intravenous injection/infusion ampoule (193608)

23 November 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FRESOFOL 1% MCT/LCT propofol 200mg/20mL emulsion for intravenous injection/infusion ampoule.
VINORELBINE KABI vinorelbine (as tartrate) 10 mg/1 mL concentrated injection vial Cancelled under S30(1)

13 September 2016

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
VINORELBINE KABI vinorelbine (as tartrate) 50 mg/5 mL concentrated injection vial Cancelled under S30(1)

13 September 2016

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
METHOTREXATE KABI methotrexate 1 g / 40 mL solution for injection vial Cancelled under S30(1)

13 September 2016

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
FRESENIUS PACLITAXEL paclitaxel 300mg/50mL injection vial Cancelled under S30(1)

13 September 2016

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
FRESENIUS PACLITAXEL paclitaxel 100mg/16.7mL injection vial Cancelled under S30(1)

13 September 2016

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
FRESENIUS PACLITAXEL paclitaxel 30mg/5mL injection vial Cancelled under S30(1)

13 September 2016

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
Fresenius Kabi Australia Pty Limited - Elastomeric infusion pump system Cancelled under s41GL(d) of the Act

6 September 2016

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
Fresenius Kabi Australia Pty Limited - Infusion administration set, infusion pump Cancelled under s41GL(d) of the Act

6 September 2016

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
Fresenius Kabi Australia Pty Limited - Haemoglobin IVDs (202398)

26 October 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Fresenius Kabi Australia Pty Limited - Haemoglobin IVDs.

Pages

First page
Previous page
…
Page 31
Page 32
Page 33
Page 34
Current page 35
Page 36
Page 37
Page 38
Page 39
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.